219 related articles for article (PubMed ID: 15984045)
1. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
3. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
4. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients.
Comper WD; Osicka TM; Jerums G
Am J Kidney Dis; 2003 Feb; 41(2):336-42. PubMed ID: 12552494
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of two-dimensional differential gel electrophoresis using cerebrospinal fluid from neurocysticercosis patients].
Li JY; Tian XJ; Huang Y; Yang YJ; Ma QR; Xue YP
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):174-8. PubMed ID: 19160961
[TBL] [Abstract][Full Text] [Related]
7. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
9. Proteome profile of human urine with two-dimensional liquid phase fractionation.
Soldi M; Sarto C; Valsecchi C; Magni F; Proserpio V; Ticozzi D; Mocarelli P
Proteomics; 2005 Jul; 5(10):2641-7. PubMed ID: 15912557
[TBL] [Abstract][Full Text] [Related]
10. [Differentially expressed urine protein of contrast induced acute kidney injury by two-dimensional differential in-gel electrophoresis and mass spectrometry].
Wang L; Ni ZH; Xie ZS; Yang FQ; He B; Liu JP; Dai HL; Yan YC; Qian JQ
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(32):2250-3. PubMed ID: 22094089
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the urine proteome of human contrast-induced kidney injury using two-dimensional fluorescence differential gel electrophoresis/matrix-assisted laser desorption time-of-flight mass spectrometry/liquid chromatography mass spectrometry.
Wang L; Ni Z; Xie Z; Yang F; He B; Liu J; Dai H; Qian J; Jia M
Am J Nephrol; 2010; 31(1):45-52. PubMed ID: 19887787
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
Agarwal R
Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.
Lapolla A; Seraglia R; Molin L; Williams K; Cosma C; Reitano R; Sechi A; Ragazzi E; Traldi P
J Mass Spectrom; 2009 Mar; 44(3):419-25. PubMed ID: 19165811
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis of serum from type 2 diabetics with nephropathy.
Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
[TBL] [Abstract][Full Text] [Related]
16. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
17. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human urine proteome by preparative electrophoresis in combination with 2-DE.
Zerefos PG; Vougas K; Dimitraki P; Kossida S; Petrolekas A; Stravodimos K; Giannopoulos A; Fountoulakis M; Vlahou A
Proteomics; 2006 Aug; 6(15):4346-55. PubMed ID: 16807940
[TBL] [Abstract][Full Text] [Related]
19. Markedly increased urinary preprohaptoglobin and haptoglobin in passive Heymann nephritis: a differential proteomics approach.
Ngai HH; Sit WH; Jiang PP; Thongboonkerd V; Wan JM
J Proteome Res; 2007 Aug; 6(8):3313-20. PubMed ID: 17616219
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS).
Lehmensiek V; Süssmuth SD; Brettschneider J; Tauscher G; Felk S; Gillardon F; Tumani H
J Neuroimmunol; 2007 Apr; 185(1-2):190-4. PubMed ID: 17367871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
